Haematology Research, Murdoch Children's Research Institute, Parkville, VIC, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
Pediatr Crit Care Med. 2024 Nov 1;25(11):1017-1025. doi: 10.1097/PCC.0000000000003591. Epub 2024 Aug 13.
To characterize surface-bound proteins and to measure the thickness of fibrin fibers bound to extracorporeal membrane oxygenation (ECMO) circuits used in children.
Single-center observational prospective study, April to November 2021.
PICU, Royal Children's Hospital, Melbourne, Australia.
Patients aged less than 18 years on venoarterial ECMO and without preexisting disorder.
None.
ECMO circuits were collected from six patients. Circuit samples were collected from five different sites, and subsequently processed for proteomic and scanning electron microscopy (SEM) studies. The concentration of proteins bound to ECMO circuit samples was measured using a bicinchoninic acid protein assay, whereas characterization of the bound proteome was performed using data-independent acquisition mass spectrometry. The Reactome Over-representation Pathway Analyses tool was used to identify functional pathways related to bound proteins. For the SEM studies, ECMO circuit samples were prepared and imaged, and the thickness of bound fibrin fibers was measured using the Fiji ImageJ software, version 1.53c ( https://imagej.net/software/fiji/ ). Protein binding to ECMO circuit samples and fibrin networks showed significant intra-circuit and interpatient variation. The median (range) total protein concentration was 19.0 (0-76.9) μg/mL, and the median total number of proteins was 2011 (1435-2777). A total of 933 proteins were commonly bound to ECMO circuit samples from all patients and were functionally involved in 212 pathways, with signal transduction, cell cycle, and metabolism of proteins being the top three pathway categories. The median intra-circuit fibrin fiber thickness was 0.20 (0.15-0.24) μm, whereas the median interpatient fibrin fiber thickness was 0.18 (0.15-0.21) μm.
In this report, we have characterized proteins and fiber fibrin thickness bound to ECMO circuits in six children. The techniques and approaches may be useful for investigating interactions between blood, coagulation, and the ECMO circuit and have the potential for circuit design.
描述表面结合蛋白的特征,并测量与体外膜氧合(ECMO)回路结合的纤维蛋白纤维的厚度,这些回路用于儿童。
2021 年 4 月至 11 月的单中心观察性前瞻性研究。
澳大利亚墨尔本皇家儿童医院 PICU。
年龄小于 18 岁且接受静脉动脉 ECMO 治疗且无预先存在的疾病的患者。
无。
从六名患者中收集 ECMO 回路。从五个不同部位采集回路样本,随后进行蛋白质组学和扫描电子显微镜(SEM)研究。使用二辛可宁酸蛋白测定法测量结合 ECMO 回路样本的蛋白质浓度,而结合蛋白质组的特征使用数据非依赖性采集质谱法进行。使用 Reactome 过表达途径分析工具来识别与结合蛋白相关的功能途径。对于 SEM 研究,制备 ECMO 回路样本并进行成像,并使用 Fiji ImageJ 软件版本 1.53c(https://imagej.net/software/fiji/)测量结合的纤维蛋白纤维的厚度。ECMO 回路样本和纤维蛋白网络的蛋白质结合显示出明显的回路内和患者间差异。总蛋白浓度的中位数(范围)为 19.0(0-76.9)μg/mL,总蛋白数的中位数为 2011(1435-2777)。共有 933 种蛋白质共同结合到所有患者的 ECMO 回路样本上,并参与了 212 种途径,其中信号转导、细胞周期和蛋白质代谢是前三个途径类别。回路内纤维蛋白纤维的中位数厚度为 0.20(0.15-0.24)μm,而患者间纤维蛋白纤维的中位数厚度为 0.18(0.15-0.21)μm。
在本报告中,我们对六名儿童的 ECMO 回路结合蛋白和纤维纤维厚度进行了特征描述。这些技术和方法可能有助于研究血液、凝血和 ECMO 回路之间的相互作用,并有可能用于回路设计。